Aktie A3EP1L BIOTRICITY, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Biotricity, Inc.

Aktien

A3EP1L

US09074H2031

BTCY

Verzögert Nasdaq
Andere Börsenplätze
 17:58:33 26.04.2024 		% 5 Tage % 1. Jan.
1.29 USD -0.77% Intraday Chart für Biotricity, Inc. -4.44% +12.17%
02.04. Biotricity kündigt strategische Partnerschaft für Herzscreenings bei Patienten mit Komorbiditäten an CI
12.03. Biotricity gibt bekannt, dass sich die Margen durch die jüngsten Weiterentwicklungen der firmeneigenen KI-Cloud-Plattform verbessert haben und kündigt Pläne für den weiteren Ausbau der KI-Cloud an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Top Premarket Decliners
Biotricity, Inc. announced that it has received $2 million in funding
Biotricity announces a strategic partnership for cardiac screenings in patients with co-morbidities
Biotricity : Certificate of Incorporation/Bylaws - Form 8-K
Biotricity Announces Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities
Biotricity, Inc. announced a financing transaction
Biotricity Unveils That Improved Margins Resulted from Latest Advancements to Its Proprietary Cardiac Ai Cloud Platform and Announces Plans for Continued Expansion of Its Cardiac AI Cloud
Biotricity, Inc. Solidifies It's Presence in the Healthcare Landscape
Biotricity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Biotricity Inc. Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 Billion Heartbeats
Biotricity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Biotricity Releases Another Groundbreaking Product: Biotres Pro
Biotricity Files Patent for Wearable Heart Monitoring Device Bioheart
Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device
Biotricity, Inc. Announces Patent Filing for Cutting-Edge Biotres Device
Biotricity reports strong growth for its first quarter fiscal year 2024 and provides financial results and business updates
Biotricity, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
Biotricity shows continued growth and strength in its fundamentals on its path to profitability
Biotricity Expands Amazon, Google Partnership for Remote Cardiac Monitoring Technology
Biotricity Inc. Expands Its Proprietary AI Model and Deepens Relationship with Amazon Aws and Google's Tensor Flow for Remote Cardiac Care Applications
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EP1L Aktie
  4. Nachrichten Biotricity, Inc.
  5. Andere Sprachen